Integer Holdings Corporation
Plano, Texas, United States · Biotechnology, Healthcare, Health Care · 11,000 employees
Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets.
Funding history
- Funding Round — $247.2M — Nov 2015
Recent signals
- Oct 23, 2025: SEC 8-K (5.02): On October 23, 2025, Integer Holdings Corporation's Board of Directors appointed Payman Khales as a member of the Board, effective October 24, 2025, as part of a previously disclosed transition plan. Mr. Khales will also assume the role of President and Chief Executive Officer (CEO) on the same date, indicating a significant change in leadership. Additionally, he will serve on the Company's Technology Strategy Committee, a role that suggests a continued focus on technological advancements within the organization. His term as a director is set to last until the next annual meeting of stockholders, which is significant for governance continuity.
- Apr 24, 2025: Integer Holdings Corporation Appoints Payman Khales as President and CEO
- Apr 09, 2025: Integer Holdings Corp. Appoints Lindsay Krause Blackwood as SVP, General Counsel and Sanjiv Arora as SVP of Strategy
- Mar 14, 2025: Integer Holdings Corporation Pricing of Convertible Notes Offering
- Nov 01, 2024: Integer Holdings Corporation Completes Divestiture of Non-Medical Business for $50 Million
- Nov 18, 2015: Raised $247.2M
See plans & pricing → Track Integer Holdings Corporation’s funding, hiring, and signals — with verified contacts — on Fundz.